NJ State Employees Deferred Compensation Plan - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 1 filers reported holding ACCELERON PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NJ State Employees Deferred Compensation Plan ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2021$1,721,000
+37.1%
10,0000.0%0.23%
+40.1%
Q2 2021$1,255,000
-7.5%
10,0000.0%0.17%
-13.5%
Q1 2021$1,357,000
+6.1%
10,0000.0%0.19%
-2.0%
Q4 2020$1,279,000
+13.7%
10,0000.0%0.20%
-2.5%
Q3 2020$1,125,000
+18.2%
10,0000.0%0.20%
+12.8%
Q2 2020$952,000
+5.9%
10,0000.0%0.18%
-13.1%
Q1 2020$899,000
+69.6%
10,0000.0%0.21%
+128.9%
Q4 2019$530,000
+34.2%
10,0000.0%0.09%
+25.0%
Q3 2019$395,000
+59.9%
10,000
+66.7%
0.07%
+63.6%
Q2 2019$247,000
-11.8%
6,0000.0%0.04%
-13.7%
Q1 2019$280,000
-8.2%
6,000
-14.3%
0.05%
-20.3%
Q4 2018$305,000
-23.9%
7,0000.0%0.06%
-5.9%
Q3 2018$401,000
+17.9%
7,0000.0%0.07%
+11.5%
Q2 2018$340,000
+24.1%
7,0000.0%0.06%
+24.5%
Q1 2018$274,000
-7.7%
7,0000.0%0.05%
-3.9%
Q4 2017$297,000
+13.8%
7,0000.0%0.05%
+8.5%
Q3 2017$261,000
+22.5%
7,0000.0%0.05%
+17.5%
Q2 2017$213,000
-16.1%
7,0000.0%0.04%
-24.5%
Q3 2016$254,000
+6.7%
7,0000.0%0.05%
+3.9%
Q2 2016$238,000
+6.7%
7,0000.0%0.05%
+8.5%
Q1 2016$223,000
-34.8%
7,0000.0%0.05%
-32.9%
Q4 2015$342,000
+54.8%
7,0000.0%0.07%
+62.8%
Q2 2015$221,000
-17.2%
7,0000.0%0.04%
-17.3%
Q1 2015$267,000
-2.2%
7,0000.0%0.05%
-1.9%
Q4 2014$273,000
+28.8%
7,0000.0%0.05%
+23.3%
Q3 2014$212,000
-10.9%
7,0000.0%0.04%
-8.5%
Q2 2014$238,000
-1.2%
7,0000.0%0.05%
-6.0%
Q1 2014$241,0007,0000.05%
Other shareholders
ACCELERON PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 42,030$3,777,0006.01%
Artal Group S.A. 1,500,000$134,805,0005.70%
GREAT POINT PARTNERS LLC 535,627$48,137,0005.03%
KINGDON CAPITAL MANAGEMENT, L.L.C. 211,038$18,966,0003.47%
Cormorant Asset Management, LP 825,000$74,143,0003.44%
Graticule Asia Macro Advisors LLC 48,700$4,377,0003.20%
Avoro Capital Advisors LLC 860,000$77,288,0002.61%
QVT Financial LP 120,264$10,808,0002.52%
Ikarian Capital, LLC 316,900$28,480,0002.14%
Avidity Partners Management LP 166,000$14,918,0002.06%
View complete list of ACCELERON PHARMA INC shareholders